Brdsnest Lemmy
  • Communities
  • Create Post
  • Create Community
  • heart
    Support Lemmy
  • search
    Search
  • Login
  • Sign Up
☆ Yσɠƚԋσʂ ☆@lemmy.ml to Science@lemmy.mlEnglish · 6 hours ago

Silencing the expression of the MTCH2 protein in human cells made them “immune” to obesity.

link.springer.com

external-link
message-square
2
fedilink
7
external-link

Silencing the expression of the MTCH2 protein in human cells made them “immune” to obesity.

link.springer.com

☆ Yσɠƚԋσʂ ☆@lemmy.ml to Science@lemmy.mlEnglish · 6 hours ago
message-square
2
fedilink
MTCH2 controls energy demand and expenditure to fuel anabolism during adipogenesis - The EMBO Journal
link.springer.com
external-link
Mitochondrial carrier homolog 2 (MTCH2) is a regulator of apoptosis, mitochondrial dynamics, and metabolism. Loss of MTCH2 results in mitochondrial fragmentation, an increase in whole-body energy utilization, and protection against diet-induced obesity. In this study, we used temporal metabolomics on HeLa cells to show that MTCH2 deletion results in a high ATP demand, an oxidized cellular environment, and elevated utilization of lipids, amino acids, and carbohydrates, accompanied by a decrease in several metabolites. Lipidomics analysis revealed a strategic adaptive reduction in membrane lipids and an increase in storage lipids in MTCH2 knockout cells. Importantly, MTCH2 knockout cells showed an increase in mitochondrial oxidative function, which may explain the higher energy demand. Interestingly, this imbalance in energy metabolism and reductive potential triggered by MTCH2-deletion prevents NIH3T3L1 preadipocytes from differentiating into mature adipocytes, an energy consuming reductive biosynthetic process. In summary, the loss of MTCH2 leads to increased mitochondrial oxidative activity and energy demand, creating a catabolic and oxidative environment that fails to fuel the anabolic processes required for lipid accumulation and adipocyte differentiation.
alert-triangle
You must log in or register to comment.
  • SubArcticTundra@lemmy.ml
    link
    fedilink
    arrow-up
    2
    ·
    5 hours ago

  • db2@lemmy.world
    link
    fedilink
    arrow-up
    2
    ·
    5 hours ago

    Cool, but mitochondrial fragmentation sounds wholly unpleasant. I’ll pass if they do human trials. 🤣

Science@lemmy.ml

science@lemmy.ml

Subscribe from Remote Instance

Create a post
You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !science@lemmy.ml

Subscribe to see new publications and popular science coverage of current research on your homepage


Visibility: Public
globe

This community can be federated to other instances and be posted/commented in by their users.

  • 78 users / day
  • 285 users / week
  • 708 users / month
  • 2.27K users / 6 months
  • 1 local subscriber
  • 21.7K subscribers
  • 1.78K Posts
  • 5.2K Comments
  • Modlog
  • mods:
  • MinutePhrase@lemmy.ml
  • BE: 0.19.5
  • Modlog
  • Instances
  • Docs
  • Code
  • join-lemmy.org